BioDelivery Sciences International, Inc. (NASDAQ: BDSI) is a specialty pharmaceutical that seeks to address the unmet needs of patients suffering from Chronic and debilitating conditions. BELBUCA® (buprenorphine) is a buccal film that provides long-acting pain relief, by leveraging its BioErodible MucoAdhesive (BEMA®) technology, and is...
Melinta Therapeutics (NASDAQ: MLNT), a commercial-stage pharmaceutical Company, engaged in developing therapeutic options for treatment of bacterial infectious diseases, filed for Chapter 11 bankruptcy in January 2020. The Company had concerns about its financial prospects and warned the investors that it would be difficult to...
Nio, Inc (NYSE: NIO), a Chinese electric vehicle manufacturer, has announced an agreement with Xpeng Motors, for sharing charging stations, pertinent information as well as services, with an eye to boost EV demand and reduce costs. The agreement will enable customers of Nio and Xpeng to...
XBiotech Inc (NASDAQ: XBIT), a clinical-stage Biopharmaceutical Company engaged in developing and commercializing True Human monoclonal antibodies, has announced the signing of a definitive agreement with Janssen Biotech, Inc., a pharmaceutical company of Johnson & Johnson (NYSE: JNJ), for the sale of its novel antibody...
MedPharm set to launch First-of-Its kind Cannabis-based Clinical Trial in Alzheimer MedPharm Holdings, an acquisition target of Medicine Man Technologies (OTCQX: MDCL), is all set to launch a landmark, double-blind, placebo controlled clinical trial which will evaluate the effect of cannabis on patients with Dementia and...
Profound Medical Corp (NASDAQ: PROF), a medical technology Company that offers magnetic resonance guided ablation procedures, announced the approval of its TULSA-PRO® system for the ablation of low to intermediate risk organ-confined prostate cancer by Heath Canada. The Company develops innovative, customizable, incision-free and radiation free...
